Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ECYT
5376
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $40K | ﹤0.01% |
15,706
+7,232
| +85% | +$16.7K |
|
|
UFS
5377
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
| $40K | ﹤0.01% |
1,100
-2,700
| -71% | -$107K |
|
5378
CALL
Cheniere Energy
CQP
$31.9B
| $39K | ﹤0.01% |
1,200
-11,200
| -90% | -$346K |
|
5379
PUT
Enovis
ENOV
$1.68B
| $39K | ﹤0.01% |
581
-1,917
| -77% | -$128K |
|
5380
FB Financial Corp
FBK
$3.02B
| $39K | ﹤0.01% |
+1,106
| New | +$32.6K |
|
5381
Genie Energy
GNE
$367M
| $39K | ﹤0.01% |
5,400
+5,164
| +2,188% | +$30.3K |
|
|
HTBK
5382
DELISTED
Heritage Commerce
HTBK
| $39K | ﹤0.01% |
2,768
+2,178
| +369% | +$30.6K |
|
5383
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.26B
| $39K | ﹤0.01% |
510
-104
| -17% | -$7.88K |
|
5384
PUT
Northern Oil and Gas
NOG
$2.3B
| $39K | ﹤0.01% |
1,500
-390
| -21% | -$12K |
|
5385
POSCO
PKX
$16.1B
| $39K | ﹤0.01% |
606
-1,269
| -68% | -$75.9K |
|
|
RNET
5386
DELISTED
RigNet, Inc.
RNET
| $39K | ﹤0.01% |
1,870
+1,422
| +317% | +$28.3K |
|
|
ACHN
5387
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
| $39K | ﹤0.01% |
9,300
-66,700
| -88% | -$277K |
|
|
STBZ
5388
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $39K | ﹤0.01% |
1,511
-273
| -15% | -$7.22K |
|
|
GNRT
5389
DELISTED
Gener8 Maritime, Inc.
GNRT
| $39K | ﹤0.01% |
6,827
+6,247
| +1,077% | +$31.1K |
|
5390
CALL
Teucrium Corn Fund
CORN
$176M
| $38K | ﹤0.01% |
2,000
-22,200
| -92% | -$428K |
|
5391
CTS Corp
CTS
$1.83B
| $38K | ﹤0.01% |
1,821
+1,164
| +177% | +$25.7K |
|
5392
CALL
Helen of Troy
HELE
$644M
| $38K | ﹤0.01% |
400
-4,300
| -91% | -$406K |
|
5393
ICF International
ICFI
$1.46B
| $38K | ﹤0.01% |
937
-227
| -20% | -$11K |
|
5394
LifeVantage
LFVN
$81.1M
| $38K | ﹤0.01% |
7,165
-10,959
| -60% | -$69.2K |
|
5395
PUT
NETSCOUT
NTCT
$2.96B
| $38K | ﹤0.01% |
1,000
-1,000
| -50% | -$35.3K |
|
5396
Tandem Diabetes Care
TNDM
$1.34B
| $38K | ﹤0.01% |
3,189
+3,185
| +79,625% | +$69.6K |
|
5397
CALL
ProShares UltraShort Russell2000
TWM
$44.3M
| $38K | ﹤0.01% |
85
-150
| -64% | -$68.9K |
|
|
OIG
5398
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
| $38K | ﹤0.01% |
+202
| New | +$48.4K |
|
|
VSI
5399
CALL
DELISTED
Vitamin Shoppe Inc.
VSI
| $38K | ﹤0.01% |
1,900
-6,100
| -76% | -$130K |
|
|
WP
5400
CALL
DELISTED
Worldpay, Inc.
WP
| $38K | ﹤0.01% |
600
+400
| +200% | +$25.4K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.